News

In the late 1970s, the United States banned the production of an assortment of synthetic pesticides, insulators, coolants and flame retardants due to their toxicity and the fact that they stick around for a long time. However, nature makes compounds similar to these toxic human-made substances – and that could be a concern.

The self-stopping nanoparticles could soon be used as part of hyperthermic-thermotherapy to treat patients with cancer.

New research shows that a new class of antiviral drugs works by causing the virus' replication machinery to pause and backtrack, preventing the virus from efficiently replicating. This discovery, made possible by a high-throughput experimental technique called "magnetic tweezers," could speed the development and approval of related antiviral drugs.

By pairing an anti-EGFR drug with a “tail” that only activates the drug when it is very near tumor cells, tarloxitinib brings the drug to tumors while keeping concentrations safe in surrounding tissues.

Local organizations set up alongside employee groups at Restek to speak with employees about volunteer opportunities.

Appointment supports continued expansion of the group and completes leadership team.

Now, for the first time, scientists at Rutgers University–New Brunswick and other institutions have discovered a “molecular pencil sharpener” that chews away its outer coating to release the powerful antibiotic.

Microscopic and spectroscopic analyses reveal a super-thin carbon coating on biochar is key to its enhanced fertilizing capabilities.

In the largest study of its kind, five new malaria vaccine targets have been discovered by scientists at the Wellcome Trust Sanger Institute and their collaborators.

Researchers have successfully tested a new molecule capable of preventing the development of peripheral neuropathy induced by chemotherapy in cancer patients, especially in colon cancer cases, the third most common neoplasm in the world.